Giuseppe Lippi/LinkedIn
Mar 14, 2026, 12:59
Giuseppe Lippi: New Highlights on Key Aspects of Heparin Anticoagulant Therapy and Monitoring
Giuseppe Lippi, Professor at University of Verona, Dean at Faculty of Medicine and Surgery, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Happy to share our new article on ‘Heparin Anticoagulant Therapy and Its Monitoring’.”
Title: Heparin Anticoagulant Therapy and Its Monitoring
Authors: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J. Favaloro
Read the Full Article on Biomolecules
See more in the gallery.
Other posts featuring Giuseppe Lippi on Hemostasis Today.
-
Mar 14, 2026, 12:39Samwel Mikaye: Blood Smear Morphology Guide
-
Mar 14, 2026, 12:24Pradeep Natarajan: Key New Aspects of the 2026 ACC/AHA Dyslipidemia Guidelines
-
Mar 13, 2026, 22:57Robert Hamilton: The Reality of Stroke Care and Why 81.6% Should be a Wake-Up call
-
Mar 13, 2026, 22:05Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
-
Mar 13, 2026, 21:29Timothy Glidewell: Genetic Signals of Platelet and Clotting Pathways in Cryptogenic Stroke
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A